LOCOID® cream and ointment (hydrocortisone butyrate 0.1%) are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid- responsive dermatoses.

LOCOID® solution (hydrocortisone butyrate 0.1 %) is indicated for the relief of the inflammatory and pruritic manifestations of seborrheic dermatitis.

LOCOID© cream or ointment (hydrocortisone butyrate 0.1%) should be applied to the affected area as a thin film two or three times daily depending on the severity of the condition.

Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions.

If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.

LOCOID® solution (hydrocortisone butyrate 0.1%) should be applied to the affected area as a thin film two or three times daily depending on the severity of the condition.

LOCOID® cream (hydrocortisone butyrate 0.1%) is supplied in tubes containing:

15 g NDC 0496-0802-15
45 g NDC 0496-0802-45

LOCOID® ointment (hydrocortisone butyrate 0.1%) is supplied in tubes containing:

15 g NDC 0496-0803-15
45 g NDC 0496-0803-45

LOCOID® solution (hydrocortisone butyrate 0.1%) is supplied in polyethylene bottles containing:

20 ml NDC 0496-0804-20
60 ml NDC 0496-0804-60

STORAGE CONDITIONS:

LOCOID® (hydrocortisone butyrate) cream 0.1 %: Store between 59° - 77° F (15° -25° C).

LOCOID® (hydrocortisone butyrate) ointment 0.1 %: Store between 36° - 86°deg; F (2° - 30° C).

LOCOID® (hydrocortisone butyrate) solution 0.1 %: Store between 41°- 77°deg; F (5° - 25° C).

Distributed by:
FERNDALE LABORATORIES, INC. FERNDALE, MICHIGAN 48220 USA. Manufactured by:Yamanouchi Europe B.V. Leiderdorp/The Netherlands. FDA rev date: 5/18/2007

Last reviewed on RxList: 3/20/2008
This monograph has been modified to include the generic and brand name in many instances.